Cargando…
The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer
Drug metabolism-associated genes have been clarified to play a vital role in the process of cancer cell growth and migration. Nevertheless, the correlation between drug metabolism-associated genes and gastric cancer (GC) has not been fully explored and clarified. This paper has focused on the role o...
Autores principales: | Cai, Yuan, Zeng, Rong, Peng, Jinwu, Liu, Wei, He, Qingchun, Xu, Zhijie, Bai, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512493/ https://www.ncbi.nlm.nih.gov/pubmed/36098688 http://dx.doi.org/10.18632/aging.204270 |
Ejemplares similares
-
ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2018) -
ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients
por: Wang, Shangqian, et al.
Publicado: (2020) -
Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis
por: Chen, Yan, et al.
Publicado: (2018) -
Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022) -
Downregulated exosome-associated gene FGF9 as a novel diagnostic and prognostic target for ovarian cancer and its underlying roles in immune regulation
por: Xu, Zhijie, et al.
Publicado: (2022)